Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (51-60 of 287) with videos related to

Pageof 29
Sort By:
Natural Immunity|October 28, 1998
Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humansP Lissoni, F Rovelli, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1994
Normalization of idiopathic arterial hypertension following cancer immunotherapy with interleukin-2P Lissoni, A Bastone, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|February 28, 2002
Abrogation of surgery-induced IL-6 hypersecretion by presurgical immunotherapy with IL-2 and its importance in the prevention of postoperative complicationsF Brivio, P Lissoni, M S Perego, et al.
The International Journal of Biological Markers|July 1, 1997
Neopterin, soluble IL-2 receptor and IL-6 secretion during IL-2 cancer immunotherapy: prognostic significance in relation to IL-12 variationsP Lissoni, S Barni, G Di Felice, et al.
In Vivo (Athens, Greece)|November 10, 2005
Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapyP Lissoni, F Brivio, L Fumagalli, et al.
The International Journal of Biological Markers|April 14, 2000
Effects of oncological surgery on endothelin-1 secretion in patients with operable gastric cancerA Ferrari-Bravo, C Franciosi, P Lissoni, et al.
Oncology|January 1, 1990
Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasmsG Tancini, S Barni, R Rescaldani, et al.
British Journal of Cancer|November 1, 1990
Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patientsP Lissoni, G Tancini, F Rovelli, et al.
Tumori|February 28, 1993
A weekly schedule of epirubicin in pretreated advanced breast cancerS Barni, C Archili, P Lissoni, et al.
The European Journal of Medicine|September 1, 1992
Enhanced secretion of tumour necrosis factor in patients with myocardial infarctionP Lissoni, F Pelizzoni, O Mauri, et al.
Pageof 29

Showing results (51-60 of 287) with videos related to

Sort By:
Pageof 29
Natural Immunity|October 28, 1998
Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humansP Lissoni, F Rovelli, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1994
Normalization of idiopathic arterial hypertension following cancer immunotherapy with interleukin-2P Lissoni, A Bastone, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|February 28, 2002
Abrogation of surgery-induced IL-6 hypersecretion by presurgical immunotherapy with IL-2 and its importance in the prevention of postoperative complicationsF Brivio, P Lissoni, M S Perego, et al.
The International Journal of Biological Markers|July 1, 1997
Neopterin, soluble IL-2 receptor and IL-6 secretion during IL-2 cancer immunotherapy: prognostic significance in relation to IL-12 variationsP Lissoni, S Barni, G Di Felice, et al.
In Vivo (Athens, Greece)|November 10, 2005
Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapyP Lissoni, F Brivio, L Fumagalli, et al.
The International Journal of Biological Markers|April 14, 2000
Effects of oncological surgery on endothelin-1 secretion in patients with operable gastric cancerA Ferrari-Bravo, C Franciosi, P Lissoni, et al.
Oncology|January 1, 1990
Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasmsG Tancini, S Barni, R Rescaldani, et al.
British Journal of Cancer|November 1, 1990
Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patientsP Lissoni, G Tancini, F Rovelli, et al.
Tumori|February 28, 1993
A weekly schedule of epirubicin in pretreated advanced breast cancerS Barni, C Archili, P Lissoni, et al.
The European Journal of Medicine|September 1, 1992
Enhanced secretion of tumour necrosis factor in patients with myocardial infarctionP Lissoni, F Pelizzoni, O Mauri, et al.
Pageof 29